Kolon TissueGene, Inc.
Founded in 1999 and listed on KOSDAQ in 2017, Kolon TissueGene is developing the osteoarthritis cell and gene therapy TG-C, now in US Phase 3 trials.
Price
Change
Market cap
Products & technology
- TG-CCell and gene therapy for osteoarthritis
R&D and key agreements
Source: DART corporate disclosureTG-C 무릎골관절염(Knee OA) · 무릎골관절염 · 미국 FDA 임상3상(2개 Pivotal study, 2024년 7월 1,066명 환자등록 완료, 추적관찰중) · Dosing began in 2018 but was voluntarily paused in 2019 over a possible cell-origin error, leading to an FDA Clinical Hold; the company received a Remove Clinical Hold Letter in 2020 and resumed dosing in December 2021. It plans to file for FDA approval (BLA) after the follow-up period ends.
TG-C 고관절골관절염(Hip OA) · 고관절골관절염 · FDA 임상2상 승인 · Received FDA approval for a Phase 2 trial, though the company plans to prioritize the more advanced knee osteoarthritis program.
TG-C 퇴행성척추디스크질환(DDD) · 퇴행성 척추 디스크질환 · 전임상 완료, FDA IND 승인(2023년 12월) · Preclinical animal studies showed a significant reduction in pain from damaged discs after TG-C injection; based on this data, the company submitted an IND to the FDA and received approval in December 2023.
Companies in the same categoryPharma & CDMO
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Founded and listed on KOSDAQ in 2015, Kolmar BioTech is a nonclinical CRO providing efficacy testing for anticancer and metabolic disease drug candidates.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition